| Oct 8 |
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
|
| Sep 16 |
Bio-Path Holdings Announces Publication in Biomedicines
|
| Sep 4 |
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24
|
| Sep 3 |
Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 21 |
What Happened With Bio-Path Stock Today?
|
| Aug 21 |
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors
|
| Aug 15 |
Bio-Path Holdings, Inc. (BPTH) Q2 2024 Earnings Call Transcript
|
| Aug 15 |
Bio-Path: Q2 Earnings Snapshot
|
| Aug 15 |
Bio-Path GAAP EPS of -$1.16
|
| Aug 15 |
Bio-Path Holdings Reports Second Quarter 2024 Financial Results
|
